Evidence 360 Summit
Real-World Evidence, Market Access & Pricing — where evidence generation, payer strategy and commercial access converge to shape how therapies reach patients.
Basel's Evidence 360 Summit
The Evidence 360 Summit returns to Basel for its 3rd annual edition, bringing together real-world evidence leaders, market access strategists, HEOR specialists and pricing experts navigating an increasingly evidence-driven access landscape.
Across two days, delegates will explore how robust RWE is strengthening HTA submissions, informing value-based pricing, and accelerating patient access across major and emerging markets. Hosted in Basel, a global centre for pharmaceutical decision-making, the summit brings the RWE and access community together at the heart of Europe.
Two Parallel Tracks
Real-World Evidence & HEOR
- Building fit-for-purpose RWE strategies across the product lifecycle
- Real-world data sources: registries, claims, EHRs and hybrid trials
- AI and advanced analytics in evidence generation
- Strengthening HTA dossiers with real-world outcomes data
- Regulatory-grade RWE: FDA and EMA expectations
- Panel: closing the evidence gap between trials and clinical practice
Market Access & Pricing
- Value-based pricing and outcomes-based agreements
- Navigating HTA pathways across Europe, the US and emerging markets
- Payer engagement strategy and early access programmes
- Pricing and reimbursement for cell, gene and orphan therapies
- Global launch sequencing and access strategy
- Panel: adapting to evolving HTA and pricing regulation
What makes the 3rd edition different
RWE-Driven HTA Submissions
How real-world data is strengthening value dossiers and reimbursement outcomes.
AI in Evidence Generation
Advanced analytics and AI transforming real-world data into decision-grade evidence.
Value-Based & Outcomes-Based Pricing
Emerging pricing models linking payment to real-world therapeutic outcomes.
Global Access & Launch Strategy
Sequencing market entry across mature and emerging healthcare systems.
Payer & HTA Perspectives
Direct insight from payers and HTA bodies on evolving evidence requirements.
Networking Reception
A dedicated Day 1 evening reception for informal, high-value conversations.
Built for the people who build the field
Stay ahead of policy shifts
Latest developments in HTA regulation, pricing frameworks and payer expectations.
Build high-value connections
Network with senior decision-makers through structured sessions and panels.
Access expert perspectives
Hear from leaders across pharma, payers, HTA bodies and consultancies.
Gain commercial intelligence
Cross-functional panels bridging evidence, access and commercial strategy.
A senior, multidisciplinary audience
RWE & HEOR Leaders
Evidence strategy across the product lifecycle.
Market Access Teams
Pricing, reimbursement and payer negotiation.
HTA & Regulatory Affairs
Evolving global HTA and approval pathways.
Payers & Health Authorities
Value assessment and outcomes-based agreements.
Health Economists
Modelling, budget impact and cost-effectiveness.
Pricing & Reimbursement Leads
Global launch and pricing sequencing strategy.
Consultancies & Advisory Firms
Access strategy and evidence generation support.
Pharma & Biopharma Leaders
Commercial and evidence-driven access strategy.
Who will be in the room
Indicative audience composition based on Veridon Global's RWE & market access community.
Audience by Sector
Seniority Breakdown
Attendee Domains
Agenda & speaker panel
Full Agenda — Coming Soon
The detailed two-day session schedule is being finalised and will be published shortly.
Speaker Lineup — Being Confirmed
2027 speakers are currently being confirmed. Full announcements will follow shortly.
Sponsorship opportunities are open
Position your organisation in front of RWE, market access and pricing decision-makers. All tiers remain available for the 3rd edition.
Platinum
Premier branding & speaking slot
OpenGold
Prominent visibility & panel seat
OpenSilver
Brand presence & delegate access
OpenExhibitor
Capped exhibition booth space
OpenBuilt as a business development platform
Sponsoring the summit gives your team structured access to senior RWE, access and pricing decision-makers — not just passive brand awareness.
Curated Introductions
Get connected with the delegates most relevant to your organisation, arranged ahead of the summit.
Flexible Speaking Slots
Choose preferred speaking slots and shape presentation topics aligned with your priorities.
Focused Exhibition
A carefully managed exhibition space designed for genuine visibility rather than overcrowding.
Dual Audience Reach
Engage both evidence and access decision-makers across the full programme.
Post-Event Follow-Up
Structured, permission-based delegate follow-up after the summit closes.
Brand Visibility
Presence across the event site, signage and delegate communications.
Basel, Switzerland
A global hub for pharmaceutical decision-making, Basel offers world-class connectivity at the heart of Europe.
Easy to reach, easy to stay
Basel is served by EuroAirport Basel-Mulhouse-Freiburg with direct connections across Europe, and sits within easy reach of Zurich and Geneva. The city hosts major pharmaceutical headquarters and access decision-makers, making it the natural setting for a summit at the intersection of evidence and access. Venue and accommodation details will be shared as the date approaches.
Register or enquire about sponsorship
For registration, speaking opportunities, or sponsorship enquiries, our team is ready to assist.
By submitting this form, you agree to share your details with Veridon Global for enquiry follow-up.